Mupirocin is an FDA approved monoxycarbolic acid antibiotic indicated in the treatment of bacterial skin infections. The active pharmaceutical ingredient is used in topical preparations. Mupirocin is used for the treatment of impetigo. It’s effective in treating gram-positive bacteria such as Streptococcus pyogenes and Staphylococcus aureus (MRSA) that are methicillin resistant.

Mupirocin is appropriate for use in treating some gram-negative bacteria. It’s a low resistance drug, but it has very specific uses as it is not effective for most anaerobic bacteria or fungal or yeast infections.

Pharmaceutica North America provides Mupirocin as a Bulk Active Pharmaceutical Ingredient (API). The purity and strength of API’s ensure that you are providing your patients with a stable,
safe medication of the highest standards.